Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): a systematic review
Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): a systematic review
Purpose of Review Intravesical antibiotics (IVA) has been used for prophylaxis and treatment of recurrent urinary tract infections (rUTIs). However, there is a lack of comprehensive evidence and consensus on its use. We conducted a systematic review to collect all available data about the effectiveness of IVA in prevention and treatment of rUTIs and to give an overview on the outcomes to date. Methods A systematic review was carried out for all English language articles from inception to August 2017, according to the Cochrane and PRISMA standards using MEDLINE, Scopus, Biomed Central, EMBASE, CINAHL, and Web of Science with references cross-checked and individual urology journals hand-searched. Results After an initial identification of 658 studies,we screened 37 abstracts and 18 full-text papers of which 11 were included in our final review. This included 285 patients with a mean age of 52 years and a female:male ratio of 129:117. The IVA used was gentamicin, neomycin/polymyxin, neomycin or colistin and IVA was used for rUTIs as prophylaxis in 5 studies (n = 168) and treatment in 6 studies (n = 117). Overall, a good reduction in symptomatic UTI was seen in 78%, with a short-term success rate and discontinuation rates of 71% (120/168) and 8% (14/168) in the prophylaxis group and 88% (103/117) and 5% (6/117) in the treatment groups respectively. There was a change in the sensitivity of organisms in 30% (50/168) and 23% (27/117) in the treatment and prophylaxis groups respectively. Twenty patients discontinued their IVA instillations which were higher for the non-gentamicin group (11%) compared to the gentamicin group (5%). The side effects were minor and included allergy, suprapubic discomfort, autonomic dysreflexia, urinary tract infections and diarrhoea. Summary Intravesical antimicrobial instillation seems to be a relatively safe and effective method for the prophylaxis and treatment of recurrent UTIs, especially in the short term. It gives clinicians an alternative treatment modality in high-risk patients predisposed to UTIs where all other forms of systemic treatments have failed.
Antimicrobial resistance, Intravesical antibiotics, Recurrent, Urinary infection, UTI
Pietropaolo, Amelia
dd6770c4-bf2e-46a9-b7a2-7bd3f9fdba56
Jones, Patrick
d27beb5b-0e09-4ed5-89f0-6c62421c2397
Moors, Mike
43b329b2-4708-44cf-9c9a-105a3478eb73
Birch, Brian
8a94cd36-d429-4ab4-82a6-a376b4d4e10f
Somani, Bhaskar K.
ab5fd1ce-02df-4b88-b25e-8ece396335d9
1 October 2018
Pietropaolo, Amelia
dd6770c4-bf2e-46a9-b7a2-7bd3f9fdba56
Jones, Patrick
d27beb5b-0e09-4ed5-89f0-6c62421c2397
Moors, Mike
43b329b2-4708-44cf-9c9a-105a3478eb73
Birch, Brian
8a94cd36-d429-4ab4-82a6-a376b4d4e10f
Somani, Bhaskar K.
ab5fd1ce-02df-4b88-b25e-8ece396335d9
Pietropaolo, Amelia, Jones, Patrick, Moors, Mike, Birch, Brian and Somani, Bhaskar K.
(2018)
Use and effectiveness of antimicrobial intravesical treatment for prophylaxis and treatment of recurrent urinary tract infections (UTIs): a systematic review.
Current Urology Reports, 19 (10).
(doi:10.1007/s11934-018-0834-8).
Abstract
Purpose of Review Intravesical antibiotics (IVA) has been used for prophylaxis and treatment of recurrent urinary tract infections (rUTIs). However, there is a lack of comprehensive evidence and consensus on its use. We conducted a systematic review to collect all available data about the effectiveness of IVA in prevention and treatment of rUTIs and to give an overview on the outcomes to date. Methods A systematic review was carried out for all English language articles from inception to August 2017, according to the Cochrane and PRISMA standards using MEDLINE, Scopus, Biomed Central, EMBASE, CINAHL, and Web of Science with references cross-checked and individual urology journals hand-searched. Results After an initial identification of 658 studies,we screened 37 abstracts and 18 full-text papers of which 11 were included in our final review. This included 285 patients with a mean age of 52 years and a female:male ratio of 129:117. The IVA used was gentamicin, neomycin/polymyxin, neomycin or colistin and IVA was used for rUTIs as prophylaxis in 5 studies (n = 168) and treatment in 6 studies (n = 117). Overall, a good reduction in symptomatic UTI was seen in 78%, with a short-term success rate and discontinuation rates of 71% (120/168) and 8% (14/168) in the prophylaxis group and 88% (103/117) and 5% (6/117) in the treatment groups respectively. There was a change in the sensitivity of organisms in 30% (50/168) and 23% (27/117) in the treatment and prophylaxis groups respectively. Twenty patients discontinued their IVA instillations which were higher for the non-gentamicin group (11%) compared to the gentamicin group (5%). The side effects were minor and included allergy, suprapubic discomfort, autonomic dysreflexia, urinary tract infections and diarrhoea. Summary Intravesical antimicrobial instillation seems to be a relatively safe and effective method for the prophylaxis and treatment of recurrent UTIs, especially in the short term. It gives clinicians an alternative treatment modality in high-risk patients predisposed to UTIs where all other forms of systemic treatments have failed.
Text
Pietropaolo2018_Article_UseAndEffectivenessOfAntimicro
- Version of Record
More information
e-pub ahead of print date: 9 August 2018
Published date: 1 October 2018
Keywords:
Antimicrobial resistance, Intravesical antibiotics, Recurrent, Urinary infection, UTI
Identifiers
Local EPrints ID: 423783
URI: http://eprints.soton.ac.uk/id/eprint/423783
ISSN: 1527-2737
PURE UUID: 80ef7b05-266e-4746-ba06-9e7cf7cead76
Catalogue record
Date deposited: 01 Oct 2018 16:30
Last modified: 15 Mar 2024 21:25
Export record
Altmetrics
Contributors
Author:
Amelia Pietropaolo
Author:
Patrick Jones
Author:
Mike Moors
Author:
Brian Birch
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics